Small Molecule Discovery
Hyper ADME/T
In medicinal chemistry, it is essential to evaluate ADME/T suitability—Absorption (A), Distribution (D), Metabolism (M), Excretion (E), and Toxicity (T)—based on the physicochemical properties of a compound.
Hyper ADME/T is a feature that predicts the PK/PD properties and toxicity of registered molecules using AI.
Small Molecule Discovery
Hyper ADME/T
Hyper ADME/T is a feature that predicts the PK/PD properties and toxicity of registered molecules using AI.
In medicinal chemistry, it is essential to evaluate ADME/T suitability
—Absorption (A), Distribution (D), Metabolism (M), Excretion (E), and Toxicity (T)
—based on the physicochemical properties of a compound.
Small Molecule Discovery
Hyper ADME/T
Hyper ADME/T is a feature that predicts the PK/PD properties and toxicity of registered molecules using AI.
Consider in vitro ADME/T from the early stages of drug development
From the early stages of drug development, incorporating in vitro ADME/T prediction values can increase the success rate of drug development.
Predict with just one click
With just one click, you can check 19 essential property prediction values critical for drug development.
Freely select the molecules you want based on ADME/T prediction values
Apply filtering based on the prediction values to select molecules. Multiple physical property criteria can be applied simultaneously.
Consider in vitro ADME/T from the early stages of drug development
From the early stages of drug development, incorporating in vitro ADME/T prediction values can increase the success rate of drug development.
Predict with just one click
With just one click, you can check 19 essential property prediction values critical for drug development.
Freely select the molecules you want based on ADME/T prediction values
Apply filtering based on the prediction values to select molecules. Multiple physical property criteria can be applied simultaneously.
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
—
AI drug discovery Platform
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
—
AI drug discovery Platform
Small Molecule Discovery
Publications
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu,
Seoul, Republic of Korea
© HITS Inc. All rights reserved.